- Home
- INCR
INCR
Intercure Ltd.
as 05-30-2025 4:00pm EST
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
| Founded: | 1994 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 76.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 8.6K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.41 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.17 - $3.28 | Next Earning Date: | 05-01-2025 |
| Revenue: | $65,575,323 | Revenue Growth: | -32.82% |
| Revenue Growth (this year): | 69.54% | Revenue Growth (next year): | 41.75% |
Latest Intercure Ltd. News
INCR Breaking Stock News: Dive into INCR Ticker-Specific Updates for Smart Investing
PR Newswire
a month ago
InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025
PR Newswire
4 months ago
InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak
PR Newswire
5 months ago
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility
Market Exclusive
9 months ago
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
GlobeNewswire
9 months ago
InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million
MT Newswires
9 months ago
InterCure Partners with Cookies to Launch Branded Products in Germany
Business Wire
9 months ago
InterCure Announces Expansion of its Strategic partnership with Cookies to Germany
CNW Group
a year ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Compare INCR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INCR Intercure Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.